Of note, we found that MYOCD mRNA level in clinical samples was almost universally low as reflected by Fragments Per Kilobase of transcript per Million (FPKM) in RNA-sequencing data of 994 lung cancer samples analyzed (FPKM<1 in 98% patients). This evidence concerns the gene MYOCD and lung carcinoma.